We are live on ! Find out more
FDCDDQ

Federation des caisses Desjardins du Quebec Portfolio holdings

AUM $27.8B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+6.65%
1 Year Est. Return
+31.66%
3 Year Est. Return
+71.4%
5 Year Est. Return
+81.76%
10 Year Est. Return
AUM
$9.08B
AUM Growth
+$635M
Cap. Flow
+$308M
Cap. Flow %
3.4%
Top 10 Hldgs %
24.14%
Holding
2,439
New
122
Increased
600
Reduced
773
Closed
91

Top Sells

Rank Stock Value
1
MFC icon
Manulife Financial
MFC
+$20.6M
2
AVGO icon
Broadcom
AVGO
+$18.2M
3
INTU icon
Intuit
INTU
+$17.2M
4
EWG icon
iShares MSCI Germany ETF
EWG
+$14.8M
5
NVDA icon
NVIDIA
NVDA
+$13.7M

Sector Composition

Rank Sector Weight
1 Financials 26.5%
2 Technology 13.35%
3 Communication Services 9.13%
4 Industrials 7.73%
5 Healthcare 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VGFC
2276
DELISTED
The Very Good Food Company
VGFC
$104 ﹤0.01%
12,975
EMBK
2277
DELISTED
Embark Technology, Inc. Common Stock
EMBK
$101 ﹤0.01%
36
NSTB.WS
2278
DELISTED
Northern Star Investment Corp. II Redeemable warrants, each whole warrant exercisable for shares of Class A common stock at an exercise price of $11.50 per share
NSTB.WS
$96 ﹤0.01%
4,000
AMTD
2279
AMTD IDEA Group
AMTD
$72.2M
$94 ﹤0.01%
20
TNXP icon
2280
Tonix Pharmaceuticals
TNXP
$215M
0
BAND
2281
Bandwidth Inc
BAND
$1.73B
$91 ﹤0.01%
6
CMCL icon
2282
Caledonia Mining Corp
CMCL
$442M
$91 ﹤0.01%
6
GOEVW
2283
DELISTED
Canoo Inc. Warrant
GOEVW
$90 ﹤0.01%
1,000
ARVL
2284
DELISTED
Arrival Ordinary Shares
ARVL
$90 ﹤0.01%
14
GRCE
2285
Grace Therapeutics
GRCE
$43.3M
$85 ﹤0.01%
31
AKBA icon
2286
Akebia Therapeutics
AKBA
$241M
$84 ﹤0.01%
150
CHRN
2287
ChronoScale Holdings
CHRN
$3.01B
$83 ﹤0.01%
3
IMNN icon
2288
Imunon
IMNN
$6.64M
$82 ﹤0.01%
5
BHR
2289
Braemar Hotels & Resorts
BHR
$140M
$77 ﹤0.01%
20
AINC
2290
DELISTED
Ashford Inc.
AINC
$76 ﹤0.01%
6
HGEN
2291
DELISTED
HUMANIGEN, INC.
HGEN
$75 ﹤0.01%
520
VEON icon
2292
VEON
VEON
$3.95B
$71 ﹤0.01%
4
XP icon
2293
XP
XP
$8.19B
$71 ﹤0.01%
6
BDRX
2294
Biodexa Pharmaceuticals
BDRX
$1.54M
0
DK icon
2295
Delek US
DK
$4.15B
$69 ﹤0.01%
3
TLPH icon
2296
Talphera
TLPH
$62.8M
$69 ﹤0.01%
105
APLT
2297
DELISTED
Applied Therapeutics
APLT
$68 ﹤0.01%
84
PRLB icon
2298
Protolabs
PRLB
$2.21B
$66 ﹤0.01%
2
HUBC icon
2299
Hub Cyber Security
HUBC
$25.5M
0
QUBT icon
2300
Quantum Computing Inc
QUBT
$2.01B
$59 ﹤0.01%
45
-1,955
-98% -$3.09K

Similar funds

Federation des caisses Desjardins du Quebec's Q1 2023 Portfolio in Review

As of Q1 2023, Federation des caisses Desjardins du Quebec held 2,439 positions worth $9.08B, up 7.5% from $8.44B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Federation des caisses Desjardins du Quebec deployed $308M of net new capital in Q1 2023, opening 122 new positions and adding to 600 existing holdings. Its largest new stake was Royalty Pharma: 193,115 shares worth $6.96M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Manulife Financial, an estimated $20.6M trimmed.

  • Federation des caisses Desjardins du Quebec's largest Q1 2023 buy was Royalty Pharma: 193,115 shares worth $6.96M.
  • Federation des caisses Desjardins du Quebec added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, an estimated $107M increase.
  • Federation des caisses Desjardins du Quebec's biggest Q1 2023 reduction was Manulife Financial, cutting an estimated $20.6M.
  • Federation des caisses Desjardins du Quebec fully exited Dimensional International Small Cap Value ETF in Q1 2023, selling an estimated $3.1M.
  • Federation des caisses Desjardins du Quebec's ten largest holdings make up 24% of its $9.08B portfolio in Q1 2023.
  • Federation des caisses Desjardins du Quebec opened 122 new positions and closed 91 in Q1 2023.
  • Federation des caisses Desjardins du Quebec's portfolio value rose 7.5% quarter-over-quarter to $9.08B.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2023, filed 15 Aug 2024.